Statistics from Altmetric.com
A recent Commentary in this journal1 encourages wider implementation of nucleic-acid amplification tests (NAATs) to detect gonorrhoea (GC). We have used GC NAATs (APTIMA Combo2; Gen-Probe Inc., San Diego, California, USA) since 2003, with high uptake, in a Liverpool chlamydia screening population and with referral of GC-positive patients to our local genitourinary medicine (GUM) clinic for management.2 We have now observed a doubling of female cases of GC and a reversal of the downward trend for male …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.